相关实验视频
Updated: Jan 14, 2026
08:05
Design and Analysis for Fall Detection System Simplification
Published on: April 6, 2020
11.1K
在老年人中预防跌倒的临床决策支持的有效性:系统性审查和元分析
Rune Solli1, Nina Rydland Olsen2, Linda Aimée Hartford Kvæl1,3
1Department of Rehabilitation Science and Health Technology, Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
PloS one
|January 12, 2026
概括
临床决策支持 (CDS) 可能会改善医疗保健从业人员在老年人中预防跌倒的表现. 虽然证据的确定性有所不同,但CDS可能会提高坚持,药物管理,并降低跌倒率,为未来的实施策略提供信息.
科学领域:
- 老年学是一门学科.
- 医疗信息学 医疗信息学
- 基于证据的实践.
背景情况:
- 建议使用临床决策支持 (CDS) 预防老年人落.
- 本综述评估了CDS对从业者坚持,药物治疗结果和患者结果的影响.
研究的目的:
- 系统地审查CDS干预措施对老年人跌倒预防的影响.
- 评估对医疗保健从业人员遵守推实践的影响.
- 评估对药物和患者秋季结果的影响.
主要方法:
- 在多个数据库 (Medline,EMBASE,CINAHL等) 进行了搜索. 通过2025年1月.
- 包括随机和非随机研究,比较CDS与65岁以上成年人落预防的常规护理.
- 分析了从业人员的表现,药物治疗结果,跌倒风险,跌倒率和跌倒伤害,使用元分析和GRADE确定性评估.
主要成果:
- CDS可能会提高从业人员的坚持 (低确定性) 和药物审查/处方 (中等确定性).
- CDS可能会降低医院/住院护理和80岁以上 (中等确定性) 患者的跌倒率.
- 在社区居住的老年人或65-80岁的老年人中,对跌倒风险和跌倒率的影响可能很小;关于跌倒伤害的证据不确定.
结论:
- CDS可能会提高医疗保健从业人员在老年人防摔方面的表现.
- 患者结果的改善是可能的,但效果大小和证据确定性各不相同.
- 结果可以为CDS的规划和实施提供信息;未来的研究需要更清楚地报告CDS设计因素.
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
01:15Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
227
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
227